Emend 125 / 80 mg, 3 capsules (Aprepitant 125 mg) by Merck Sharp & Dohme.
Indications: Prevention of acute and delayed nausea and vomiting associated with highly and moderately emetogenic chemotherapy.
Administration: Oral: 125 mg 1 hour before chemotherapy on day 1, then 80 mg on days 2 and 3, as part of a combination regimen.
Storage: Store below 25–30 °C in the original package. Keep out of the sight and reach of children.
Prescription-only medicine (POM). Supplied against a valid prescription / to licensed healthcare professionals only.
| Manufacturer | Merck Sharp & Dohme (MSD) |
| Active ingredient | Aprepitant 125 mg (1 capsule) + 80 mg (2 capsules) — NK1 receptor antagonist. |
| Strength & pack | 3-day pack: 1 × 125 mg + 2 × 80 mg capsules. |
| Form | Hard capsules |
| Storage | Store below 25–30 °C in the original package. Keep out of the sight and reach of children. |
| Regulatory status | Prescription-only medicine (POM). Supplied against a valid prescription / to licensed healthcare professionals only. |